A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is
Collaborations between academic institutions and the diagnostics/pharmaceutical industry are increasingly being initiated and executed. It's assumed that these relationships could help to improve research and development productivity in industry, as well as enable academic institutions to better exploit the translational potential of their research. Identification and validation of targets and biomarkers, key elements of successful drug discovery, are challenging. Unfortunately accordingdoi:10.5281/zenodo.32666 fatcat:y5llag5i6vahdc6tfywxamqyxi